New York Life Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,640
| Closed | -$361K | – | 971 |
|
|
2024
Q1 | $361K | Buy |
+22,640
| New | +$361K | ﹤0.01% | 1197 |
|
|
2023
Q1 | – | Sell |
-68,427
| Closed | -$1.27M | – | 1242 |
|
|
2022
Q4 | $1.27M | Buy |
68,427
+7,340
| +12% | +$137K | 0.01% | 592 |
|
|
2022
Q3 | $784K | Buy |
61,087
+4,834
| +9% | +$62K | 0.01% | 639 |
|
|
2022
Q2 | $394K | Buy |
+56,253
| New | +$394K | ﹤0.01% | 980 |
|